Older adults consistently experience more severe outcomes from respiratory infections like COVID-19 and influenza, facing a higher risk of hospitalization, complications and even death. While age itself is a known risk factor, scientists are now gaining a more nuanced understanding of why the aging process makes individuals so vulnerable. New research from the University of California, San Francisco, points to a surprising culprit: changes within the structural cells of the lungs, triggering an overactive immune response that ultimately harms the body.
The study, published Thursday in the journal Immunity, identifies lung fibroblasts – cells responsible for maintaining the structure of lung tissue – as key drivers of “inflammaging,” the chronic, low-grade inflammation that accumulates with age. This discovery could pave the way for targeted therapies designed to interrupt this damaging cycle and protect older adults from the worst effects of respiratory viruses. Understanding the mechanisms behind increased susceptibility to COVID-19 and seasonal flu is crucial as populations worldwide continue to age.
The Unexpected Role of Lung Fibroblasts
Researchers initially sought to understand how age-related changes in lung tissue contribute to inflammation. To do so, they genetically modified young mice to exhibit characteristics of aging fibroblasts – specifically, the ability to send out age-related distress signals. The results were striking. Even in otherwise healthy lungs, these signals triggered an immune response, attracting immune cells from the bloodstream and forming clusters of inflammation.
Crucially, the study identified a specific immune cell, marked by the GZMK gene, as playing a detrimental role. While these GZMK cells are typically involved in fighting off infections, the researchers found that they were ineffective against the virus but actively contributed to lung damage. The presence of these inflamed cell clusters mirrored what scientists observed in the lungs of older individuals, effectively recreating the hallmarks of aging in a younger model.
When the GZMK cells were removed through genetic manipulation, the young mice were able to better withstand infection, suggesting that the aging lung tissue itself is a primary instigator of the inflammatory cascade. This isn’t limited to viral infections; fibroblasts also contribute to inflammation in chronic lung diseases like Chronic Obstructive Pulmonary Disease (COPD).
Echoes of COVID-19: Persistent Inflammation in Severe Cases
The findings resonated with observations made during the COVID-19 pandemic. “We saw during COVID that our most vulnerable patients no longer had the infection but still had persistent and devastating lung inflammation,” explained Tien Peng, MD, a professor of medicine at UCSF and senior author of the paper. “This circuit of dysfunction between lung and immune cells makes for a promising new therapeutic target.”
To confirm these findings, the researchers examined lung tissue samples from older patients hospitalized with severe COVID-19-related acute respiratory distress syndrome (ARDS). They discovered the same clusters of inflamed cells present in the mice, with sicker patients exhibiting a greater concentration of these clusters. In contrast, lung tissue from healthy donors showed no such inflammation.
“We were surprised to see lung fibroblasts working hand-in-hand with immune cells to drive inflammaging,” Dr. Peng said. “It suggests new ways to intervene before patients progress to severe inflammation that can require intubation.” This suggests that targeting the interaction between fibroblasts and immune cells could be a key strategy for preventing severe illness in older adults.
What This Means for Future Treatments
The research opens up several avenues for potential therapeutic interventions. One promising approach involves directly targeting the GZMK cells to dampen the inflammatory response. Researchers are also exploring ways to modulate fibroblast activity, preventing them from sending out the distress signals that initiate the cycle of inflammation. While a therapy is still years away, the identification of these key players represents a significant step forward.
The implications extend beyond COVID-19 and influenza. Given the role of fibroblasts in other inflammatory lung conditions, these findings could also inform the development of treatments for COPD and other age-related respiratory illnesses. The study underscores the importance of addressing the underlying mechanisms of aging to improve healthspan and resilience against infectious diseases.
As the global population continues to age, understanding the biological changes that increase vulnerability to infection is paramount. This research provides a critical piece of the puzzle, offering hope for more effective strategies to protect older adults from the devastating consequences of respiratory viruses. Further research will focus on translating these findings into clinical trials and developing targeted therapies that can interrupt the cycle of inflammaging and restore healthy lung function.
Have thoughts on this story? Share your comments below, and please share this article with anyone who might find it informative.
